NCT06700772

Brief Summary

Two groups of patients with posterior vertical deficient maxillary alveolar ridge with pneumatized sinus and needing dental implant . First group will be subjected to open sinus lifting using autogenous bone mixed with bone marrow aspirate concentrate cells from maxillary tuberosity and the second group will be subjected to open sinus lifting using autogenous bone mixed with bovine bone

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 22, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

December 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

November 22, 2024

Status Verified

November 1, 2024

Enrollment Period

1 year

First QC Date

November 16, 2024

Last Update Submit

November 19, 2024

Conditions

Keywords

Bone replacement materialsBone substitutesMaxillary sinus augmentation

Outcome Measures

Primary Outcomes (1)

  • Radiographic assessment

    Calculation of vertical bone gain quantity using cone beam computed tomography

    6 months postoperative

Secondary Outcomes (1)

  • Histomorphometric analysis

    6 months postoperative

Study Arms (2)

open sinus lifting using bone marrow aspirate from maxillary tuberosity mixed with bovine bone

EXPERIMENTAL

Under local anesthesia a 20 gauge needle that will be inserted inside tuberosity until aspiration is positive and then the aspirate will be collected in heparin treated tube (1ml anticoagulant citrate dextrose) for each 15 ml of aspirate The aspirate will be centrifuged at 3000 rpm for 10 minutes to separate the BMAC The upper layer containing the plasma and platelet will be separated using sterile peptide tube leaving the BMAC Mixing BMAC with bovine bone (2cc of bio-oss) and it will be applied in grafted sinus

Procedure: mixing bone marrow aspirate concentrate from maxillary tuberosity with bovine bone

Open sinus lifting using autogenous bone mixed with bovine bone

ACTIVE COMPARATOR

After injection of local anesthesia a crystal incision will be done from a point corresponding to occlusal surface along external oblique ridge and extending anteriorly and inferiorly through the buccal mucosa Subperiosteal dissection will be done to expose the retromolar area ACM bur will be used to collect autogenous bone and mixing it with bovine bone 50 : 50 Then this mixture will be packed into the grafted area

Procedure: mixing autogenous bone with bovine bone

Interventions

open sinus lifting using bone marrow aspirate concentrate from maxillary tuberosity and mixing it with bovine bone .

open sinus lifting using bone marrow aspirate from maxillary tuberosity mixed with bovine bone

open sinus lifting using autogenous bone from retromolar area mixed with bovine bone

Open sinus lifting using autogenous bone mixed with bovine bone

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with missing maxillary teeth with pneumatized sinus and remaining bone height \<5mm
  • Patients with healthy systemic condition (Medically free)
  • Adequate inter-arch space for placement of the implant prosthetic part.
  • Good oral hygiene
  • Cooperative patients who are willing to commit for 6 months follow up

You may not qualify if:

  • Smokers
  • Pregnant females
  • Patient with medical condition that contraindicates surgical procedures.
  • Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Chemo/radio therapy).
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits.
  • Patients have chronic sinus disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of oral and dental medicine - cairo university

Cairo, New Cairo, 12613, Egypt

RECRUITING

Faculty of oral and dental medicine - cairo university

Cairo, 12613, Egypt

RECRUITING

Related Links

Study Officials

  • Mohammed Mounir shaker

    Faculty of oral and dental medicine cairo university

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Masking Details
None. Because the two interventions used in this trial are clearly different and can be easily recognized by the participant and investigator
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A Randomized clinical trial A trial will be conducted in hospital of oral and maxillofacial surgery department.faculty of oral and dental medicine Cairo university Equal randomization of participant Both groups receiving treatment Each group of patient receiving a single treatment simultaneously
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dentist

Study Record Dates

First Submitted

November 16, 2024

First Posted

November 22, 2024

Study Start

December 1, 2024

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

November 22, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations